Embed Size (px)
Citation preview
High Risk Screening MBI, 22% Lifetime Risk by Claus Model
Case History:
• 62 y/o with recent negative screening mammography referred for management of high risk status
• Abnormal MBI scan with focal uptake posterior LIQ left breast
• Diagnostic mammography and US demonstrated no significant findings , just a subtle 1.2 cm mass at 7:00 approximately 4 cm from the nipple by US
• 9 gauge vacuum-assisted needle USCN bx results: ILC & LCIS
• Breast MRI showed 1.4 cm index lesion and adjacent 6mm ILC satellite and extensive LCIS in posterior LIQ left breast
• Final surgical pathology results: 1.2 cm ILC with adjacent 6mm ILC satellite and extensive LCIS in posterior LIQ left breast pathology staging: pT1c(m), pN0(sn), cM0, Stage 1A
LumaGEM Case Study ®
Molecular Breast Imaging (MBI) Diagnostic Mammography
Ultrasound MRI
Gamma Medica, Inc.
12 Manor Parkway, Unit 3, Salem, NH 03079 • Toll Free: +1 888.720.3152 • Tel: +1 603.952.4441 • Fax: +1 603.870.8045
Email: [email protected] • www.gammamedica.com
Images Courtesy of Houston Methodist Sugar Land Hospital, Breast Imaging Center, Houston, TX
LumaGEM is a registered trademark of Gamma Medica, Inc. © 2013 Gamma Medica, Inc. All rights reserved.
